Synovial Fibroblasts Directly Induce Th17 Pathogenicity via the Cyclooxygenase/Prostaglandin E-2 Pathway, Independent of IL-23

Sandra Paulissen, Jan piet Hamburg, Nadine Davelaar, Patrick Asmawidjaja, Mieke Hazes, Erik Lubberts

Research output: Contribution to journalArticleAcademicpeer-review

74 Citations (Scopus)

Abstract

Th17 cells are critically involved in autoimmune disease induction and severity. Recently, we showed that Th17 cells from patients with rheumatoid arthritis (RA) directly induced a proinflammatory loop upon interaction with RA synovial fibroblasts (RASF), including increased autocrine IL-17A production. To unravel the mechanism driving this IL-17A production, we obtained primary CD4(+)CD45RO(+)CCR6(+) (Th17) cells and CD4(+)CD45RO(+) CCR6(-) (CCR6(-)) T cells from RA patients or healthy individuals and cocultured these with RASF. IL-1 beta, IL-6, IL-23p19, and cyclooxygenase (COX)-2 expression and PGE(2) production in Th17-RASF cultures were higher than in CCR6(-) T cell-RASF cultures. Cytokine neutralization showed that IL-1 beta and IL-6, but not IL-23, contributed to autocrine IL-17A induction. Importantly, treatment with celecoxib, a COX-2 inhibitor, resulted in significantly lower PGE(2) and IL-17A, but not IFN-gamma, production. Combined celecoxib and TNF-alpha blockade more effectively suppressed the proinflammatory loop than did single treatment, as shown by lower IL-6, IL-8, matrix metalloproteinase-1 and matrix metalloproteinase-3 production. These findings show a critical role for the COX-2/PGE(2) pathway in driving Th17-mediated synovial inflammation in an IL-23- and monocyte-independent manner. Therefore, it would be important to control PGE(2) in chronic inflammation in RA and potentially other Th17-mediated autoimmune disorders.
Original languageUndefined/Unknown
Pages (from-to)1364-1372
Number of pages9
JournalJournal of Immunology
Volume191
Issue number3
DOIs
Publication statusPublished - 2013

Cite this